Manulife (Manufacturers Life Insurance)
PRTK

Manulife (Manufacturers Life Insurance)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,868
Closed -$73.9K – 3202
2022
Q1 		$73.9K Sell
24,868
-3,368
-12% -$12.7K ﹤0.01% 3004
2021
Q4 		$127 Buy
28,236
+5,716
+25% +$27.1K ﹤0.01% 3017
2021
Q3 		$109K Sell
22,520
-6,973
-24% -$38.4K ﹤0.01% 3095
2021
Q2 		$201K Buy
29,493
+1,184
+4% +$9.57K ﹤0.01% 3101
2021
Q1 		$200K Sell
28,309
-410
-1% -$2.95K ﹤0.01% 2896
2020
Q4 		$180K Buy
28,719
+2,554
+10% +$15K ﹤0.01% 2812
2020
Q3 		$142K Hold
26,165
– – ﹤0.01% 2699
2020
Q2 		$134K Buy
26,165
+3,380
+15% +$15K ﹤0.01% 2650
2020
Q1 		$72K Buy
22,785
+1,862
+9% +$6.87K ﹤0.01% 2667
2019
Q4 		$84K Buy
20,923
+475
+2% +$1.65K ﹤0.01% 2821
2019
Q3 		$94K Buy
+20,448
New +$81.8K ﹤0.01% 2837
2019
Q2 		– Sell
-23,599
Closed -$126K – 2973
2019
Q1 		$126K Buy
23,599
+1,350
+6% +$8.72K ﹤0.01% 2544
2018
Q4 		$114K Sell
22,249
-1,061
-5% -$8.06K ﹤0.01% 2425
2018
Q3 		$227K Sell
23,310
-2,240
-9% -$22.6K ﹤0.01% 2695
2018
Q2 		$260K Buy
25,550
+4,794
+23% +$54.2K ﹤0.01% 2912
2018
Q1 		$270K Buy
20,756
+2,051
+11% +$30.5K ﹤0.01% 2788
2017
Q4 		$335K Buy
18,705
+395
+2% +$8.24K ﹤0.01% 2604
2017
Q3 		$460K Sell
18,310
-340
-2% -$7.91K ﹤0.01% 2330
2017
Q2 		$449K Buy
18,650
+3,233
+21% +$71.5K ﹤0.01% 2374
2017
Q1 		$297K Buy
15,417
+1,746
+13% +$27.5K ﹤0.01% 2550
2016
Q4 		$211K Buy
13,671
+977
+8% +$12.7K ﹤0.01% 2743
2016
Q3 		$165K Buy
12,694
+1,491
+13% +$19.8K ﹤0.01% 2919
2016
Q2 		$156K Buy
11,203
+2,290
+26% +$33.7K ﹤0.01% 2915
2016
Q1 		$143K Buy
8,913
+258
+3% +$3.95K ﹤0.01% 2847
2015
Q4 		$164 Buy
8,655
+203
+2% +$3.88K ﹤0.01% 2804
2015
Q3 		$161 Buy
8,452
+176
+2% +$4.39K ﹤0.01% 2822
2015
Q2 		$213 Buy
8,276
+8,262
+59,014% +$234K ﹤0.01% 2799
2015
Q1 		$0 Hold
14
– – ﹤0.01% 4052
2014
Q4 		$1 Sell
14
-355
-96% -$8.48K ﹤0.01% 3863
2014
Q3 		$0 Buy
369
+315
+583% +$8.22K ﹤0.01% 3991
2014
Q2 		$1K Hold
54
– – ﹤0.01% 3798
2014
Q1 		$2 Hold
54
– – ﹤0.01% 3662
2013
Q4 		$2 Hold
54
– – ﹤0.01% 3682
2013
Q3 		$2 Hold
54
– – ﹤0.01% 3540
2013
Q2 		$2K Buy
+54
New +$2.31K ﹤0.01% 3419

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRTK Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 24,868 shares — an estimated $73.9K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PRTK in Q2 2013 and held it in 35 quarters. The position peaked at $460K in Q3 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 24,868 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $73.9K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
  • Manulife (Manufacturers Life Insurance)'s Paratek Pharmaceuticals, Inc. position peaked at $460K in Q3 2017.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.